These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 17893002
1. C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Khan SQ, Dhillon O, Struck J, Quinn P, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. Am Heart J; 2007 Oct; 154(4):736-42. PubMed ID: 17893002 [Abstract] [Full Text] [Related]
2. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL. J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290 [Abstract] [Full Text] [Related]
3. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction. Puri A, Narain VS, Mehrotra S, Dwivedi SK, Saran RK, Puri VK. Indian Heart J; 2005 Apr 10; 57(4):304-10. PubMed ID: 16350675 [Abstract] [Full Text] [Related]
4. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. Circulation; 2007 Apr 24; 115(16):2103-10. PubMed ID: 17420344 [Abstract] [Full Text] [Related]
5. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL. Clin Sci (Lond); 2004 Sep 24; 107(3):309-16. PubMed ID: 15182235 [Abstract] [Full Text] [Related]
6. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study. Dhillon OS, Khan SQ, Narayan HK, Ng KH, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. J Am Coll Cardiol; 2010 Jul 06; 56(2):125-33. PubMed ID: 20620726 [Abstract] [Full Text] [Related]
7. Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction. Haaf P, Zellweger C, Reichlin T, Zbinden A, Wildi K, Mosimann T, Twerenbold R, Reiter M, Balmelli C, Freidank H, Gimenez MR, Peter F, Freese M, Stelzig C, Hartmann B, Dinter C, Osswald S, Mueller C. Can J Cardiol; 2014 Feb 06; 30(2):195-203. PubMed ID: 24461921 [Abstract] [Full Text] [Related]
8. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Dieplinger B, Gegenhuber A, Struck J, Poelz W, Langsteger W, Haltmayer M, Mueller T. Clin Chim Acta; 2009 Feb 06; 400(1-2):91-6. PubMed ID: 19000665 [Abstract] [Full Text] [Related]
10. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption. Maeder MT, Brutsche MH, Staub D, Morgenthaler NG, Bergmann A, Noveanu M, Laule K, Breidthardt T, Christ A, Klima T, Reichlin T, Potocki M, Mueller C. J Intern Med; 2009 May 06; 265(5):604-15. PubMed ID: 19226375 [Abstract] [Full Text] [Related]
11. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Voors AA, von Haehling S, Anker SD, Hillege HL, Struck J, Hartmann O, Bergmann A, Squire I, van Veldhuisen DJ, Dickstein K, OPTIMAAL Investigators. Eur Heart J; 2009 May 06; 30(10):1187-94. PubMed ID: 19346228 [Abstract] [Full Text] [Related]
12. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N, Christchurch Cardioendocrine Research Group, Australia-New Zealand Heart Failure Group. J Am Coll Cardiol; 2006 Jan 03; 47(1):52-60. PubMed ID: 16386664 [Abstract] [Full Text] [Related]
14. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K. J Card Fail; 2005 Sep 03; 11(7):492-7. PubMed ID: 16198243 [Abstract] [Full Text] [Related]
15. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, Buffet P, L'huillier I, Richard C, Beer JC, Touzery C, Gambert P, Zeller M, RICO survey working group. Heart; 2011 Apr 03; 97(7):551-6. PubMed ID: 21343169 [Abstract] [Full Text] [Related]